SBIR/STTR Research Award

Developing an Ideal First Use Agent to Prevent Sepsis in Trauma Wounds During Care Under Fire

Award identifier 232d1a139278398c2b634ceb182ff129e9bb79557cc423aaa2b0a0cfda1d89e9Awarding agency Department of Defense · Defense Health Agency

Award amount

$1,300,000

Program and phase

SBIR · Phase II

Award year

2025

Explore This Research Award in CaptureIQ

Research the technology, evaluate the recipient and agency, identify related opportunities, and explore potential follow-on work with CaptureIQ.

Award details

Awarding agency
Department of Defense
Branch
Defense Health Agency
Recipient company
ALTRAZEAL LIFE SCIENCES INC
Proposal award date
2025-02-06
Contract end date
2027-06-06
UEI
N24WUMUHT5V9
Solicitation number
20.2
Topic code
A20-137

Research abstract

Sepsis is the greatest danger after hemorrhage in both civilian and combat-related injuries with mortality rates ranging between 19.5 - 23%. Early intervention with appropriate antibiotics, hemodynamic optimization, and supportive care are particularly vital in preventing trauma related sepsis. Treatments to prevent trauma sepsis may be confounded by the uncontrolled bleeding which often attends severe traumatic injuries and is responsible for 40% of trauma deaths, the majority of which occur in the prehospital period. Both sepsis and hemorrhage can trigger deadly inflammatory responses causing fatal injury to tissues and organs. Rapid interventions which control bleeding while reducing contamination to diminish the high mortality and morbidity rates associated with sepsis in traumatic injuries are a critical need. Remote austere environments at point of injury often delay delivering essential medical care. In military trauma wounds, this may be further exacerbated by the hostile environment. Our proposed solution is an early application of a multi-functional wound dressing which allows dynamic release of active agents to prevent hemorrhage and sepsis with extended wear time to improve current standard of care during care under fire and prolonged field care. We hypothesize that a sustained release of antimicrobials will provide protection in the deep tissue planes of the wound and skin surface for at least 72 hours under care-under fire conditions when delivered using this wound dressing. The proposed solution will be light, easy to use, transportable and shelf-stable.

Technology keywords

Not reported

Other awards by this recipient

Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.

Awards with the same topic code

Verified by an exact topic code match. This is not a text-similarity match.

Research funding history

4 SBIR/STTR records share this UEI (2021–2025). Reported award amounts total $3,867,447. Reported amounts are not federal obligations.

Phases: Phase II, Phase I

Agencies: Department of Defense

Agency intelligence

Department of Defense

Back to SBIR/STTR Research Awards

Don't take our word for it. Ask AI about RFPCapture.

See what leading AI assistants have to say about RFPCapture and CaptureIQ.

Gemini opens without a prefilled question. The question is copied to your clipboard when the button works. You can also copy it here:

What is RFPCapture.com and its CaptureIQ platform from Smart Logic AI? How does it help federal contractors discover opportunities, evaluate bid/no-bid decisions, research government contracts, and prepare proposals? How does it compare with other federal capture platforms? Use independent sources where available.